Union Minister Dr. Jitendra Singh, speaking on the eve of Doctor's Day, detailed India's advancements in precision medicine and healthcare innovation. He emphasized that India is developing homegrown solutions to address global health challenges through gene therapy, nuclear medicine, and other emerging technologies, positioning the country as a global hub for cutting-edge healthcare innovation.
India's unique genetic diversity and heterogeneous disease profile present unprecedented opportunities to develop Indian data for Indian treatment of Indian patients. The Genome India Mission has completed genome sequencing of over 10,000 individuals and is progressing toward building one of the world's largest genomic databases, which will accelerate the country's transition to precision medicine and strengthen research into genetic disorders, rare diseases, and personalized therapies.
Significant scientific achievements include successful demonstration of gene therapy for haemophilia by Indian researchers, marking a milestone in indigenous medical innovation. Institutions such as the Tata Memorial Centre are undertaking pioneering work in nuclear medicine for cancers and other life-threatening diseases, creating new possibilities for safer and more precise treatment.
India's research ecosystem has been strengthened through the Anusandhan National Research Foundation, which integrates modern science with social sciences, humanities, and traditional knowledge systems. Policy reforms have opened new opportunities for advanced research in nuclear medicine by encouraging greater collaboration between government institutions, academia, and the private sector.
The pharmaceutical sector is shifting from manufacturing medicines discovered elsewhere to developing new drugs through indigenous research, clinical trials, and innovation, exemplified by the successful development of India's first indigenously researched antibiotics for drug-resistant infections. Initiatives such as the BioE3 Policy and Bio-RIDE Mission are accelerating research, bio-manufacturing, and healthcare innovation while promoting partnerships among research institutions, academia, startups, and industry.
India's medical devices sector is producing globally competitive technologies that strengthen affordable healthcare delivery domestically and internationally. The Ayushman Bharat program provides financial protection even for individuals with serious pre-existing illnesses, while the expansion of government medical colleges, digital health infrastructure, and telemedicine are strengthening India's healthcare network.
Preventive healthcare is emerging as a major national priority to address the growing burden of non-communicable diseases such as diabetes, cancer, and fatty liver disease, which increasingly affect younger age groups. Early detection, regular screening, public awareness, and timely intervention are seen as crucial for protecting the health of the country's youth and achieving the vision of Viksit Bharat @2047.
India's healthcare transformation has earned global recognition, with the country attracting patients from across the world while contributing innovative and cost-effective solutions to global health challenges. Continued investments in science, innovation, and collaborative research are expected to establish India as a global leader in next-generation healthcare.